Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer
Estefanía Labanca(The University of Texas MD Anderson Cancer Center), Nora M. Navone(The University of Texas MD Anderson Cancer Center), Bradley M. Broom(The University of Texas MD Anderson Cancer Center), Juan Bizzotto(Consejo Nacional de Investigaciones Científicas y Técnicas), Christopher J. Logothethis(The University of Texas MD Anderson Cancer Center), Geraldine Gueron(Consejo Nacional de Investigaciones Científicas y Técnicas), Nicolás Anselmino(Hebron University), Patricia Troncoso(The University of Texas MD Anderson Cancer Center), Paul G. Corn(Cornell University), Vikas Kundra(The University of Texas MD Anderson Cancer Center), Jiabin Dong(The University of Texas MD Anderson Cancer Center), Jun Yang(The University of Texas MD Anderson Cancer Center), Murali K. Ravoori(The University of Texas MD Anderson Cancer Center), Xinhai Wan(The University of Texas MD Anderson Cancer Center), Peter D.A. Shepherd(The University of Texas MD Anderson Cancer Center), Michael W. Starbuck(The University of Texas MD Anderson Cancer Center), Arul M. Chinnaiyan(University of Michigan)
Cited by 28
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k